Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tamara Mogilevski
Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Digestive Diseases and Sciences
Physiology
Gastroenterology
Related publications
Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Subtherapeutic Concentrations of Infliximab and Adalimumab Are Associated With Increased Disease Activity in Crohn’s Disease
Therapeutic Advances in Gastroenterology
Gastroenterology
Pgi21 - Cost-Effectiveness Analysis of Ustekinumab Versus Adalimumab, Infliximab and Vedolizumab for the Treatment of Patients With Moderately to Severe Active Crohn’s Disease for Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Persistence and Failure Rates of Adalimumab Monotherapy in Biologic-Naïve Patients With Psoriasis: A Retrospective Study
Journal of the American Academy of Dermatology
Dermatology
Safety Profile of Biologic Therapy in Polish Paediatric Patients With Crohn’s Disease
Przeglad Gastroenterologiczny
Gastroenterology
Matching-Adjusted Indirect Comparison: Secukinumab Versus Infliximab in Biologic-Naive Patients With Psoriatic Arthritis
Journal of Comparative Effectiveness Research
Health Policy
Exclusive Enteral Nutrition Versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Clinical Experience With Infliximab for Crohn’s Disease: The First 100 Patients in Edmonton, Alberta
Canadian Journal of Gastroenterology
Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
